A healthy RIS is a critical component of a healthcare facility. Make sure that yours is working the way it should to avoid lost reimbursement and reduce the risk of compliance issues.
In an era where data-driven scrutiny and patient-centered decision-making converge, the importance of defensible pricing in healthcare cannot be overstated. By strategically aligning prices with actual costs and market dynamics, providers can weather the storm of price transparency and emerge as leaders in a landscape defined by trust, competitiveness, and financial sustainability.
Register today to learn about the critical implications of the CMS OPPS Proposed Rule on Price Transparency Changes for 2024. Choose from two dates: Tuesday, August 22, or Thursday, September 14, from 11 a.m. to 12 p.m. (CDT).
Expansion—through mergers, acquisitions, joint ventures and other strategic partnerships—has become an important tool in a hospital’s strategic wheelhouse. As your footprint expands to encompass the entire continuum of care, how do you ensure your chargemaster strategy is sound and consistent?
In the ever-evolving landscape of healthcare regulations, one crucial aspect that healthcare entities must prioritize is exclusion screening.
Panacea Healthcare Solutions is proud to announce the launch of RateAnalyzer™, a benchmarking tool designed to provide actionable insights for negotiating favorable payer contracts using price transparency data.
Panacea is excited to announce its participation in the HFMA National Conference, taking place in Nashville from June 25 to June 28, 2023. The company will be exhibiting at booth number 1115, where it will launch its latest groundbreaking product, RateAnalyzer™.
Busy revenue cycle teams often overlook the basic steps of charge data management to attend to more urgent priorities. These proven steps covered in this article are pivotal to keeping “charge data management” a key operational priority.
Have the federal payment policy adjustments implemented in 2021 meaningfully reduced the pay gap between specialists and primary care physicians (PCPs)? A recent JAMA study appears to have yielded the answer: yes—but not by nearly enough.
Over the last decade, one of the most exciting areas of development in healthcare has been the growth of structural heart and interventional cardiology programs—specifically, the advancement of transcatheter valvular procedure techniques. As the ability to treat a larger population using these novel techniques expands, so must our understanding of the nuances involved in navigating the current rules and regulations from both the clinical and revenue cycle perspectives.
Restructuring a hospital’s chargemaster in this era of transparent pricing often results in material increases and decreases in line item charges to align with market norms, unit costs, or a hybrid thereof. Learn how your organization can enhance its financial performance in this environment.